Fortrea Holdings (FTRE) Gross Profit (2022 - 2026)
Fortrea Holdings (FTRE) posted Gross Profit of $123.6 million for Q1 2026, down 5.72% on a QoQ basis from $131.1 million in Q4 2025, and up 6.09% year-over-year from $116.5 million in Q1 2025.
Fortrea Holdings (FTRE) Gross Profit (2022 - 2026) Analysis & Trends
Fortrea Holdings' Gross Profit history runs 5 years deep, the most recent figure standing at $123.6 million for Q1 2026.
- Quarterly Gross Profit rose 6.09% year-over-year to $123.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $510.9 million (down 5.88% YoY) and the FY2025 annual result came in at $503.8 million, down 5.69% from the prior year.
- Gross Profit was $123.6 million for Q1 2026 at Fortrea Holdings, down from $131.1 million in the prior quarter.
- Across five years, Gross Profit topped out at $237.6 million in Q4 2022 and bottomed at $107.9 million in Q1 2024.
- A 5-year average of $146.0 million and a median of $139.0 million in 2024 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2023 — Gross Profit slumped 44.53% — and 2025, when it rose 7.97%.
- Fortrea Holdings' Gross Profit stood at $237.6 million in 2022, then slumped by 44.53% to $131.8 million in 2023, then increased by 6.9% to $140.9 million in 2024, then dropped by 6.96% to $131.1 million in 2025, then declined by 5.72% to $123.6 million in 2026.
- Business Quant data shows FTRE's Gross Profit at $123.6 million in Q1 2026, $131.1 million in Q4 2025, and $122.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.60 Mn |
| Mar 31, 2026 | 123.60 Mn |
| Dec 31, 2025 | 131.10 Mn |
| Dec 31, 2025 | 131.10 Mn |
| Sep 30, 2025 | 122.70 Mn |
| Sep 30, 2025 | 122.70 Mn |
| Jun 30, 2025 | 133.50 Mn |
| Jun 30, 2025 | 133.50 Mn |
| Mar 31, 2025 | 116.50 Mn |
| Mar 31, 2025 | 116.50 Mn |
| Dec 31, 2024 | 140.90 Mn |
| Dec 31, 2024 | 140.90 Mn |
| Sep 30, 2024 | 148.30 Mn |
| Sep 30, 2024 | 148.30 Mn |
| Jun 30, 2024 | 137.10 Mn |
| Jun 30, 2024 | 137.10 Mn |
| Mar 31, 2024 | 107.90 Mn |
| Mar 31, 2024 | 107.90 Mn |
| Dec 31, 2023 | 131.80 Mn |
| Dec 31, 2023 | 131.80 Mn |